ARTICLE | Company News
Camp4’s platform to discover CNS targets in Biogen partnership
January 11, 2020 1:32 AM UTC
Following preclinical validation of its platform in liver indications, Camp4 has entered a collaboration with Biogen to apply its platform to CNS target discovery.
Camp4 Therapeutics Corp. uses its Gene Circuitry Platform to build maps of signaling pathways and transcription factors that control gene expression in specific cells types, then uses machine learning to identify drug targets that will tune the expression levels of disease-associated genes (see “Gene Control Goals”)...